A股市值刚刚超越恒瑞医药的百济神州交出了2024年成绩单,还首次给出业绩指引。2月27日晚间,百济神州有限公司(百济神州,ONC.US;6160.HK;688235.SH)发布2024年度业绩快报,全年收入272.14亿元,同比增长56.2%,其中产品收入269.94亿元,同比增长74.1%。归母净亏损收窄至49.78亿元,归母扣非净亏损收窄至53.79亿元。百济神州2024年业绩快报此前的1月,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.